S SARS-CoV-2 Spike Glycoprotein mRNA

$ 10.50

4.9 (404) In stock

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

COVID-19, Infection Cycle

N SARS-CoV-2 Nucleocapsid mRNA

mRNA vaccines for COVID-19: what, why and how

N SARS-CoV-2 Nucleocapsid mRNA

%22N%22%20SARS-CoV-2%20Nucleocapsid%20mRNA%20(20%20ug%2C%20Transfection-ready)%20%7C%20Gentaur%20UK%2C%20US%20%26%20Europe%20Distribution%20%20%20Prod

N SARS-CoV-2 Nucleocapsid mRNA (20 ug, Transfection-ready)

SARS-CoV-2 Proteins

PDB-101: Learn: Resources to Fight the COVID-19 Pandemic: SARS-CoV-2 mRNA Vaccine

PDB-101: Learn: Resources to Fight the COVID-19 Pandemic: SARS-CoV-2 mRNA Vaccine

SARS-CoV-2: phenotype, genotype, and characterization of different variants, Cellular & Molecular Biology Letters

SARS-CoV-2 Proteins

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling

Recombinant SARS-CoV-2 Spike His Protein, CF 10549-CV-100: R&D Systems

HEK293 ACE2 NRP1 Overexpression Stable Cell Line

タンパク質発現システム